2025 PACC Miami | FOLFOX + Atezolizumab, Retifanlimab, Zolbetuximab, PIK3CA & Aspirin; Time to Catch-Up with Recent Advancements in the Management in Gastro-Intestinal Malignancies

2025 PACC Miami | FOLFOX + Atezolizumab, Retifanlimab, Zolbetuximab, PIK3CA & Aspirin; Time to Catch-Up with Recent Advancements in the Management in Gastro-Intestinal Malignancies

0% Complete

Course Overview

NA

Course Content

FOLFOX + Atezolizumab, Retifanlimab, Zolbetuximab, PIK3CA & Aspirin; Time to Catch-Up with Recent Advancements in the Management in Gastro-Intestinal Malignancies

Course Details

Duration
0.00 hour
Released
Nov 23, 2025
Last Review
Nov 23, 2025
Expires
Nov 23, 2026

Objectives

NA

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Frank Nyanin, PharmD

Disclosure

<p></p>

Accreditation

NA

Related Courses

2025 PACC Miami | Novel Treatment in cGVHD: Axatilimab/Niktimvo

2025 PACC Miami | Novel Treatment in cGVHD: Axatilimab/Niktimvo

0.00 AMA PRA Category 1 Credits™
1 Chapter
Pharmacology
Free
2025 PACC Miami | Pharmacist Involvement in CTU Scheduling Guidelines – Interventions to Help Streamline Workflows

2025 PACC Miami | Pharmacist Involvement in CTU Scheduling Guidelines – Interventions to Help Streamline Workflows

0.00 AMA PRA Category 1 Credits™
1 Chapter
Pharmacology
Free
Explore More Courses